ABSTRACT
Many skin testing devices have been commercially available over recent years, but use has been limited because of significantly greater costs of such devices. Therefore, the lancet continues to be the most widely used skin testing device in Australia. This study compared performance of another multitest device, the Bayer Quintest to the Becton Dickinson Microlance. Nineteen atopic volunteers were skin tested using histamine dihydrochloride 10 mg/ml, glycerosaline and eight allergens. In 190 tests, 6 discrepancies between the Quintest and Microlance occurred. The Microlance produced slightly larger wheals than the Quintest, reaching statistical significance in 3 allergens. We found the Quintest comparable to the Microlance in concordance of positive and negative allergen responses and in wheal size. The Quintest had higher acceptability to both participants and staff for comfort, ease of use and safety. The Quintest's major advantage is the ability to rapidly screen large numbers of subjects, especially during clinical trials. The major limitation is it's cost.